Coya Therapeutics logo

Coya Therapeutics Share Price (NASDAQ: COYA)

$6.6

-0.11

(-1.64%)

Last updated on

Check the interactive Coya Therapeutics Stock chart to analyse performance

Coya Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$6.54
    Today's High:$6.84

    Day's Volatility :4.39%

  • 52 Weeks Low:$4.65
    52 Weeks High:$10.24

    52 Weeks Volatility :54.59%

Coya Therapeutics Stock Returns

PeriodCoya Therapeutics IncIndex (Russel 2000)
3 Months
18.02%
0.0%
6 Months
-11.49%
0.0%
1 Year
7.03%
0.0%
3 Years
43.33%
-4.1%

Coya Therapeutics Inc Key Stats

Check Coya Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$6.71
Open
$6.84
Today's High
$6.84
Today's Low
$6.54
Market Capitalization
$112.2M
Today's Volume
$38.7K
52 Week High
$10.24
52 Week Low
$4.65
Revenue TTM
$423.5K
EBITDA
$-22.6M
Earnings Per Share (EPS)
$-1.24
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-63.99%

Stock Returns calculator for Coya Therapeutics Stock including INR - Dollar returns

The Coya Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Coya Therapeutics investment value today

Current value as on today

₹1,13,127

Returns

₹13,127

(+13.13%)

Returns from Coya Therapeutics Stock

₹7,843 (+7.84%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Coya Therapeutics Stock

30%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Coya Therapeutics Stock from India on INDmoney has increased by 30% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Coya Therapeutics Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Coya Therapeutics(by analysts ranked 0 to 5 stars)

Coya Therapeutics Share Price Target

What analysts predicted

Upside of 152.17%

Target:

$16.64

Current:

$6.60

Coya Therapeutics share price target is $16.64, a slight Upside of 152.17% compared to current price of $6.60 as per analysts' prediction.

Coya Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, COYA stock has moved down by -4.5%
  • COYA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 61.3%
  • Price to Sales

    ForCOYA every $1 of sales, investors are willing to pay $251.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Coya Therapeutics Technicals Summary

Sell

Neutral

Buy

Coya Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Coya Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Coya Therapeutics Inc logo
7.55%
-11.49%
7.03%
43.33%
43.33%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Coya Therapeutics Inc

Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary therapies to enhance the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It develops COYA 302, a biologic combination for subcutaneous administration intended to enhance Treg function while depleting T effector function and activated macrophages in Phase 2 trial for use in the treatment of amyotrophic lateral sclerosis, as well as frontotemporal dementia, Alzheimer's disease (AD), and Parkinson's disease. In addition, the company's pre-clinical product candidates include COYA 301, a low-dose interleukin 2 product candidate to treat AD; COYA 303, an investigational biologic combination of COYA 301 and a glucagon-like-peptide-1 receptor agonist for the treatment of inflammatory diseases; COYA 201, an antigen directed Treg-derived exosome product candidate to treat neurodegenerative, autoimmune, and metabolic diseases; COYA 206, an antigen directed Treg-derived exosome product candidate; and COYA 101. It has a collaboration with Dr. Reddy's Laboratories SA for the development and commercialization of COYA 302, an investigational combination therapy for treatment of amyotrophic lateral sclerosis. Coya Therapeutics, Inc. was founded in 2020 and is headquartered in Houston, Texas.
Organization
Coya Therapeutics
Employees
8
CEO
Dr. Arun Swaminathan Ph.D.
Industry
Miscellaneous

Key Management of Coya Therapeutics Inc

NameTitle
Dr. Howard H. Berman Ph.D.
Executive Chair
Dr. Arun Swaminathan Ph.D.
CEO & Director
Dr. Fred Grossman D.O., FAPA
President & Chief Medical Officer
Mr. David S. Snyder
CFO & COO
Dr. Michelle Frazier Ph.D.
Senior Vice President of Regulatory Affairs
Mr. Aaron Thome Ph.D.
Head of Neuroinflammation Platform
Ms. Karen King M.S.
Senior VP of Program Management & Clinical Operations

Important FAQs about investing in COYA Stock from India :

What is Coya Therapeutics share price today?

Coya Therapeutics share price today is $6.60 as on at the close of the market. Coya Therapeutics share today touched a day high of $6.84 and a low of $6.54.

What is the 52 week high and 52 week low for Coya Therapeutics share?

Coya Therapeutics share touched a 52 week high of $10.24 and a 52 week low of $4.65. Coya Therapeutics stock price today i.e. is closed at $6.60, lower by 35.55% versus the 52 week high.

How to invest in Coya Therapeutics Stock (COYA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Coya Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Coya Therapeutics Shares that will get you 0.2273 shares as per Coya Therapeutics share price of $6.60 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Coya Therapeutics Stock (COYA) from India?

Indian investors can start investing in Coya Therapeutics (COYA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Coya Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Coya Therapeutics share’s latest price of $6.60 as on August 30, 2025 at 1:29 am IST, you will get 1.5152 shares of Coya Therapeutics. Learn more about fractional shares .

What are the returns that Coya Therapeutics has given to Indian investors in the last 5 years?

Coya Therapeutics stock has given 43.33% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?